HomeStocks › MPHASIS

MPHASIS fair value — is it overvalued?

The fair value of MPHASIS (MPHASIS), built from its filed accounts — ten years of results, the method that fits this business, and what today's price already assumes.

MPHASIS (MPHASIS) fair value — is it overvalued? Price ₹2,378, P/E 23.8, P/B 4.22, ROE —. Based on 10 years of reported financials. FairStocks.
The short answer

The market expects much less from MPHASIS than it has delivered before.

At today’s share price, buyers are assuming MPHASIS grows about 0% a year, forever. Over the last ten years it actually grew about 8% a year. That is a big step down from its own record — in other words, that it stops growing altogether. Either the market can see a problem that the published accounts do not show yet, or it is expecting a slowdown that has not happened.

Price
₹2,378
Market cap
₹0.45L Cr
P/E
23.8
P/B
4.22
Unlock this valuation Fair value, every step of the working, and the PDF report Free during launch

What the market is assuming

Worked backwards from today's share price: the growth today’s price implies for MPHASIS, against what the model assumes.

Market expects
0%
growth priced into today’s price
Model assumes
8%
growth the model assumes

How to read this. The number on the left is the growth today’s share price quietly takes for granted. The number on the right is what the model actually assumes. When the two are far apart, that gap is the bet you would be taking.

Ten years, in charts

Revenue and earnings per share in ₹, return on equity and leverage as ratios — all from the filed statements.

Revenue₹0.07L → ₹0.16L Cr
181920212223242526
Earnings per share₹42.7 → ₹97.8
181920212223242526

The numbers behind them

Revenue and net profit as filed, in ₹ crore.

YearRevenueNet profitMargin
FY20186,54683812.8%
FY20197,7311,07313.9%
FY20208,8441,18513.4%
FY20219,7221,21712.5%
FY202211,9611,43112.0%
FY202313,7981,63811.9%
FY202413,2791,55511.7%
FY202514,2301,70212.0%
FY202615,8801,86311.7%

How this company gets valued — and why

This business is valued on the cash it is expected to generate, discounted back at its cost of capital — with growth taken from its own ten-year record rather than from guidance.

Discounted cash flow

Understand this method

The complete valuation

Model value per share
₹0,000
Upside
+00%
Call
XXXX

Unlock the complete valuation report

  • Fair value per share — with the full working behind it
  • Bull, base and bear cases — and what moves between them
  • Every assumption — growth, margins, cost of capital, with sources
  • Peer comparison — how rivals are priced on the same measures
  • Downloadable PDF report — the full write-up, yours to keep
Unlock this valuation — free
Free during launch · unlimited valuations · no card required

Frequently asked

Is MPHASIS overvalued?

At ₹2,378 the market is pricing in roughly 0% sustained growth, against the ~8% its own record supports. That is less than it has delivered — on these numbers the market is asking the business for less than its own record, which usually means it doubts the record repeats.

What is the intrinsic value of MPHASIS?

It is computed from the filed financial statements using the method that fits this business (discounted cash flow), with every assumption shown alongside the result. The per-share figure and the full working are in the report.

How does FairStocks calculate fair value?

From published financial statements. The method is chosen to fit the business — a bank on excess return, a regulated utility on its rate base, a conglomerate by its parts — and every assumption is shown with its source. When the numbers do not support an estimate, no estimate is published. This is an educational research tool: it reports what the model computed and does not recommend buying or selling anything.

What assumptions are used to value MPHASIS?

A cost of capital of 10.29%, growth drawn from the company's own record rather than from guidance, and the valuation method that fits the business. All of them are listed in the report, with how much each one moves the answer.